Digest Network Come funziona
Network
/
Società
Ow
Non verificato

Owkin

Di cosa scriviamo

BiotecnologiaIndustriaSaluteSoftwareTecnica

15 comunicati stampa

Guarda tutti i comunicati
12/01/2026
Multimedialità
Industria
Information Technology
Salute
Tecnica
Scienza
Biotecnologia
Owkin Brings Biology Super Intelligence Closer to Reality with New AI Infrastructure for Biological Breakthroughs
Fonte
Owkin
Emittente
Business Wire
1.00
0
12/01/2026
Owkin's Specialized Biological AI Agent Pathology Explorer Launches with Anthropic's Claude for Healthcare and Life Sciences
Fonte
Owkin
Emittente
Business Wire
1.00
0
12/01/2026
Owkin Advances Frontier Model Development for Biological Artificial Super Intelligence, Accelerated by NVIDIA
Fonte
Owkin
Emittente
Business Wire
1.00
0
03/12/2025
Software
Scienza
Farmaceutica
Information Technology
Oncologia
Tecnica
Attrezzature medico-sanitarie
Medicina - Varie
Biotecnologia
Salute
Industria
Owkin Announces International Validation Results of BRCAura: AI-Driven Screening for gBRCA Mutations Directly From Pathology Slides
Fonte
Owkin
Emittente
Business Wire
1.00
0
20/11/2025
Multimedialità
Software
Scienza
Information Technology
Tecnica
Università
Scuola/Istruzione
Biotecnologia
Salute
Mercato del lavoro
Université Paris-Saclay and Owkin: A Unique Alliance to Propel University Medical Research to the Top of the European Rankings Through AI
Fonte
Owkin
Emittente
Business Wire
1.00
0
18/11/2025
Owkin Unveils Europe’s First Pan-European Agentic Infrastructure for Biology at the Franco-German Digital Sovereignty Summit
Fonte
Owkin
Emittente
Business Wire
1.00
0
13/11/2025
Tecnica
Software
Biotecnologia
Salute
Farmaceutica
Information Technology
Industria
Owkin Announces Availability of K Pro in the AWS Marketplace SaaS Category
Fonte
Owkin
Emittente
Business Wire
1.00
0
06/05/2025
Owkin Launches K Navigator, a Ground-breaking Agentic Co-pilot to Speed up Breakthroughs in Biomedical Research by 20x
Fonte
Owkin
Emittente
Business Wire
1.00
0
27/02/2025
Sanità
Software
Farmaceutica
Oncologia
Information Technology
Tecnica
Biotecnologia
Salute
Industria
Owkin Launches ATLANTIS: An Extensive Multimodal Patient Data Discovery Program Across 7 Countries in 11 Therapeutic Areas
Fonte
Owkin
Emittente
Business Wire
1.00
0
30/01/2025
Owkin Announces First Patient Dosed in Phase I AI-optimized Clinical Trial of OKN4395, a First-in-Class EP2/EP4/DP1 Triple Inhibitor for Patients with Solid Tumors
Fonte
Owkin
Emittente
Business Wire
1.00
0

Recapiti

Social Media

Seguaci
0
Compatibilità
0